News
Safety, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of HLX301, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.. If you have the ...
Here, we validated the application of a 3D and dynamic cell culture system for in vitro PK/PD analysis of a novel and sequential combination therapy that overcomes resistance to HER2 therapies.
Rallybio plans to initiate a RLYB116 confirmatory clinical PK/PD study in the second quarter of 2025 to demonstrate improved tolerability as well as complete and sustained complement inhibition.
Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig.
Pharmacokinetic (PK) and pharmacodynamic (PD) findings from a phase 1b study of ATR inhibitor tuvusertib + anti-PD-L1 avelumab in patients with advanced unresectable solid tumors.
Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting - AAPM is the primary organization for pain medicine physicians in the U.S.
“I’m delighted to present these results at the country’s premier gathering of pain specialists,” commented Dr. Stauffer. “As they will tell you, the need to minimize opioid use and the lack of ...
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results